In pre-clinical murine GBM xenograft models we showed that protein kinase inhibitors of the indirubin family, which are known to potently inhibit GSK-3, block invasion and angiogenesis improving survival [17,18]. This evidence concerns the gene WEE1 and glioblastoma.